Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b. [electronic resource]
Producer: 19990316Description: 968-75 p. digitalISSN:- 0732-183X
- Adolescent
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- Dacarbazine -- administration & dosage
- Female
- Humans
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Interleukin-2 -- administration & dosage
- Male
- Melanoma -- drug therapy
- Middle Aged
- Neoplasm Metastasis
- Prospective Studies
- Recombinant Proteins
- Remission Induction
- Tamoxifen -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.